1-1 of 1
Teresa McClendon
Close
Sort by
Journal Articles

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse

Clinical Trials & Observations Brief Report
Craig H. Moskowitz, Jan Walewski, Auayporn Nademanee, Tamas Masszi, Edward Agura, Jerzy Holowiecki, Muneer H. Abidi, Andy I. Chen, Patrick Stiff, Simonetta Viviani, Veronika Bachanova, Anna Sureda, Teresa McClendon, Connie Lee, Julie Lisano, John Sweetenham
Journal: Blood
Blood (2018) 132 (25): 2639–2642.
https://doi.org/10.1182/blood-2018-07-861641
Published: 2018